Pacemakers
Jun 19, 2026
Understanding How Cardiac Devices are Aiding in Treatment and Prevention of Heart Disease
Heart disease remains the world's leading cause of death, claiming approximately 17.9 million lives annually (WHO, 2023). The landscape of cardiovascular care has been transformed by advanced cardiac devices from pacemakers and implantable cardioverter-defibrillators (ICDs) to ventricular assist devices (VADs) and ...
Read More...
Feb 25, 2026
Electrophysiology Devices: The Future of Cardiac Arrhythmia Management
Cardiac electrophysiology is a specialized branch of cardiology that focuses on the heart's electrical system and the diagnosis and treatment of heart rhythm disorders, known as arrhythmias. The field has evolved from simple diagnostic recordings to a highly sophisticated discipline that utilizes robotics, advanced...
Read More...
Aug 27, 2025
The Revolution of Healthcare: Smart Medical Devices Transforming the Future
The global healthcare landscape is witnessing a seismic shift, propelled by the rapid integration of smart healthcare technology into everyday medical practice. At the forefront of this transformation are smart medical devices are intelligent tools that combine advanced sensors, wireless connectivity, data analytic...
Read More...
Nov 28, 2024
FDA Clears Medtronic’s New Inpen™ App; Zimmer Biomet Gets FDA Approval for Oxford® Cementless Partial Knee; Perimeter B-Series OCT with ImgAssist AI 2.0 Shows Significant Superiority Over Standard-of-Care in Pivotal Clinical Trial; Edwards’ SAPIEN 3 Ultra RESILIA Valve Maintains Exceptional Patient Outcomes in Real-World Settings; Abbott Introduces AVEIR™ VR Leadless Pacemaker System to Indian Market; GE HealthCare’s Pristina Via Transforms Mammography with Improved Workflow and Patient Care
Medtronic Received FDA Clearance for the New Inpen™ App, Paving the Way for its Smart MDI System Launch with Simplera™ CGM On November 20, 2024, Medtronic, a global leader in healthcare technology, announced the U.S. Food and Drug Administration (FDA) clearance for its new InPen™ app, which includes advanc...
Read More...
Sep 19, 2024
Boston Scientific INGEVITY™ gets Expanded Indication and acquires Silk Road Medical; FDA Approves Philips’ LumiGuide Guidewire; Microbot Completes LIBERTY Trial Enrollment; Innovent Presents Data at ESMO 2024; Argon Medical Launches CLEANER Vac™ System
Boston Scientific Received FDA Approval For The Expanded Indication of INGEVITY™+ Pacing Leads, Allowing For Conduction System Pacing in The Left Bundle Branch Area On September 17, 2024, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval to expand the indication for th...
Read More...
Jan 11, 2024
Medtronic Announced World’s First Approval for MiniMed 780G System; CE Mark for Medtronic’s Next Generation Micra Leadless Pacing Systems; Biosense Webster Received Approval for VARIPULSE PFA Platform; Rivermark Medical Updated on Flostent System; Cala Disclosed TAPS Therapy Data for Essential Tremor; Medline Introduced Transparent Wound Dressing
Medtronic Received CE Mark for its Next Generation Micra Leadless Pacing Systems On January 5, 2024, Medtronic announced that the Micra AV2 and Micra VR2, the next generation of its industry-leading tiny, leadless pacemakers, earned the CE (Conformité Européenne) Mark. The world's tiniest pacemakers, the rMic...
Read More...
Dec 13, 2023
Understanding the Growth and the Evolving Market Dynamics of Cardiac Rhythm Management Devices
Globally, cardiovascular diseases (CVDs) stand as the primary cause of mortality, claiming an estimated 17.9 million lives in 2019 alone, which accounted for 32% of all global deaths. Among these fatalities, a staggering 85% were attributed to heart attacks and strokes. Within the spectrum of noncommunicable diseas...
Read More...
Aug 24, 2023
Smith+Nephew’s Hip Arthroplasty System; Mammotome Launched the HydroMARK Plus Breast Biopsy Site Marker; FDA Clearance for Pioneering MARS System; CE Marks for NGS-based Test Kits; BaroPace Updated on Non-Pharmacologic Hypertension and Heart Failure Treatment Trial; Quanta Completed Enrollment in Home Run Study
Smith+Nephew Launched Hip Arthroplasty System in India On August 17, 2023, The London-based orthopedic device maker Smith+Nephew announced the launch of its OR3O dual mobility system for use in primary and revision hip arthroplasty in India. The dual mobility implants have a smaller-diameter femoral hea...
Read More...
Jul 06, 2023
Enovis Acquires Novastep; Rockwell Medical Announced Collaboration with B. Braun; Dexcom G7 Received Health Canada Approval for Next-Generation CGM; Abbott’s World’s First Dual Chamber Leadless Pacemaker; Elios Vision’s Pivotal Trial of ELIOS; Synergy Spine’s Synergy Disc 2-Level IDE Trial
Enovis completed the acquisition of Novastep On June 29, 2023, Enovis, one of the largest orthopedic device companies in the world, announced that the company had completed the purchase of Novastep and its foot and ankle minimally invasive surgical (MIS) platform, which was first announced in April 2023. ...
Read More...
May 04, 2023
Apyx Medical Received FDA 510(k) Clearance for the Use of Renuvion; Medtronic’s Next-generation Micra Leadless Pacing Systems; Concept Medical’s MagicTouch Sirolimus Coated Balloon Catheter; Vivasure’s Pivotal PATCH Study; SunMed Acquires the Vyaire’s Respiratory & Anesthesia Consumables Business; Eitan Medical’s Connected Avoset™ Infusion Platform
Apyx Medical Corporation Received FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring On April 28, 2023, Apyx Medical Corporation, the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
